Satellos Bioscience Inc. Adjustments For Share-based Payments
Satellos Bioscience Inc. (MSLE) reported Adjustments For Share-based Payments of $3.23 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-27.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:AdjustmentsForSharebasedPayments · last filed 2026-03-27
| Period end | Adjustments For Share-based Payments 12 month |
|---|---|
| 2025-12-31 | $3.23M 40-F · filed 2026-03-27 |
| 2024-12-31 | $1.64M 40-F · filed 2026-03-27 |